326 related articles for article (PubMed ID: 16722610)
1. 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.
Vordermark D; Seufert I; Schwab F; Kölbl O; Kung M; Angermann C; Flentje M
Radiat Oncol; 2006 Apr; 1():10. PubMed ID: 16722610
[TBL] [Abstract][Full Text] [Related]
2. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk.
Koh ES; Tran TH; Heydarian M; Sachs RK; Tsang RW; Brenner DJ; Pintilie M; Xu T; Chung J; Paul N; Hodgson DC
Radiat Oncol; 2007 Mar; 2():13. PubMed ID: 17362522
[TBL] [Abstract][Full Text] [Related]
3. Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma.
Maraldo MV; Brodin NP; Vogelius IR; Aznar MC; Munck Af Rosenschöld P; Petersen PM; Specht L
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1232-7. PubMed ID: 22270170
[TBL] [Abstract][Full Text] [Related]
4. Cardiac chamber and coronary artery doses associated with postmastectomy radiotherapy techniques to the chest wall and regional nodes.
Krueger EA; Schipper MJ; Koelling T; Marsh RB; Butler JB; Pierce LJ
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1195-203. PubMed ID: 15519792
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
6. [Radiotherapy in adults with localized supradiaphragmatic stages CS I/II of Hodgkin's disease. 2. The special aspects of radiotherapy: dosage, fractionation, focal volumes, risks, conclusions].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Oct; 169(10):570-83. PubMed ID: 8235981
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin's lymphoma.
Cella L; Liuzzi R; Conson M; Torre G; Caterino M; De Rosa N; Picardi M; Camera L; Solla R; Farella A; Salvatore M; Pacelli R
Radiother Oncol; 2011 Nov; 101(2):316-21. PubMed ID: 21925755
[TBL] [Abstract][Full Text] [Related]
8. Influence of different treatment techniques on radiation dose to the LAD coronary artery.
Nieder C; Schill S; Kneschaurek P; Molls M
Radiat Oncol; 2007 Jun; 2():20. PubMed ID: 17547777
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
10. Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study).
Jacob S; Camilleri J; Derreumaux S; Walker V; Lairez O; Lapeyre M; Bruguière E; Pathak A; Bernier MO; Laurier D; Ferrieres J; Gallocher O; Latorzeff I; Pinel B; Franck D; Chevelle C; Jimenez G; Broggio D
Radiat Oncol; 2019 Feb; 14(1):29. PubMed ID: 30732640
[TBL] [Abstract][Full Text] [Related]
11. Individualized 3D reconstruction of normal tissue dose for patients with long-term follow-up: a step toward understanding dose risk for late toxicity.
Ng A; Brock KK; Sharpe MB; Moseley JL; Craig T; Hodgson DC
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e557-63. PubMed ID: 22929861
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.
Adams MJ; Lipsitz SR; Colan SD; Tarbell NJ; Treves ST; Diller L; Greenbaum N; Mauch P; Lipshultz SE
J Clin Oncol; 2004 Aug; 22(15):3139-48. PubMed ID: 15284266
[TBL] [Abstract][Full Text] [Related]
13. Mantle fields in the era of dynamic multileaf collimation: field shaping and electronic tissue compensation.
Davis QG; Paulino AC; Miller R; Ting JY
Med Dosim; 2006; 31(3):179-83. PubMed ID: 16905447
[TBL] [Abstract][Full Text] [Related]
14. Doses to carotid arteries after modern radiation therapy for Hodgkin lymphoma: is stroke still a late effect of treatment?
Maraldo MV; Brodin P; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):297-303. PubMed ID: 23910709
[TBL] [Abstract][Full Text] [Related]
15. Estimation of doses to heart, coronary arteries, and spinal cord in mediastinal irradiation for Hodgkin's disease.
Vijayakumar S; Rosenberg I; Spelbring D; Brandt T
Med Dosim; 1991 Dec; 16(4):237-41. PubMed ID: 1764176
[TBL] [Abstract][Full Text] [Related]
16. Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction.
Hahn E; Jiang H; Ng A; Bashir S; Ahmed S; Tsang R; Sun A; Gospodarowicz M; Hodgson D
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1116-1123. PubMed ID: 28721895
[TBL] [Abstract][Full Text] [Related]
17. Impact of post-operative radiation on coronary arteries in patients of early breast cancer: A pilot dosimetric study from a tertiary cancer care center from India.
Roy S; Mondal D; Melgandi W; Jana M; Chowdhury KK; Das S; Haresh KP; Gupta S; Sharma D; Julka PK; Rath GK
Indian J Cancer; 2015; 52(1):114-7. PubMed ID: 26837996
[TBL] [Abstract][Full Text] [Related]
18. Coronary artery dosimetry in intact left breast irradiation.
Storey MR; Munden R; Strom EA; McNeese MD; Buchholz TA
Cancer J; 2001; 7(6):492-7. PubMed ID: 11769861
[TBL] [Abstract][Full Text] [Related]
19. Does mean heart dose sufficiently reflect coronary artery exposure in left-sided breast cancer radiotherapy? : Influence of respiratory gating.
Becker-Schiebe M; Stockhammer M; Hoffmann W; Wetzel F; Franz H
Strahlenther Onkol; 2016 Sep; 192(9):624-31. PubMed ID: 27389036
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
